HDR Partners divests Hermes Medical Solutions to Segulah

HDR Partners Corporate Finance has advised Hermes Medical Solutions in the divestment to Segulah

Hermes Medical Solutions provides systems and software for integrating, visualizing, processing and archiving multi-format imaging data from scanning devices within molecular imaging and radi-ology. The systems are primarily used by physicians enabling faster and more accurate diagnosis and treatment of patients, thereby increasing efficiency for hospitals. Hermes is vendor-neutral and can integrate data from any scanning device (e.g. PET, CT, MRI and SPECT) irrespective of man-ufacturer or model, as well as third party planning and reporting systems.
Segulah is a private equity firm based in Stockholm that invests in Nordic mid-market companies.

mobile: +46 70 190 75 53 e-mail: ar@hdrpartners.se

HDR Partners is a leading, independent Swedish Corporate Finance advisor to owners, manage-ments and boards of directors. We assist our clients on; acquiring and divesting companies (M&A), public transactions such as initial public offerings (IPO) and public bids, as well as equity financing. Our clients are Nordic private and public companies as well as private equity firms. With a focus on private M&A, HDR Partners has over the years become a leading advisor in divesting and acquiring entrepreneurial companies. HDR Partners has since inception in 2005 advised on over 60 transactions, making us one of the most transaction-intensive advisors in the business.